RaQualia Pharma Inc. (TYO:4579)

RaQualia Pharma Revenue

RaQualia Pharma had revenue of 801.00M JPY in the quarter ending March 31, 2026, a decrease of -17.03%. This brings the company's revenue in the last twelve months to 3.81B, up 11.39% year-over-year. In the year 2025, RaQualia Pharma had annual revenue of 3.98B with 28.07% growth.

• Revenue (ttm): 3.81B
• Revenue Growth: +11.39%
• P/S Ratio: 3.51
• Revenue / Employee: 44.88M
• Employees: 85
• Market Cap: 13.38B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.98B	872.00M	28.07%
Dec 31, 2024	3.11B	1.21B	63.44%
Dec 31, 2023	1.90B	-1.02B	-34.85%
Dec 31, 2022	2.92B	142.00M	5.12%
Dec 31, 2021	2.78B	1.67B	150.77%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error